Vericel Long Term Investments vs Total Assets Analysis

VCEL Stock

USD 59.11 2.40 4.23%

Vericel Corp financial indicator trend analysis is much more than just breaking down Vericel Corp Ord prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vericel Corp Ord is a good investment. Please check the relationship between Vericel Corp Long Term Investments and its Total Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Long Term Investments vs Total Assets

Long Term Investments vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vericel Corp Ord Long Term Investments account and Total Assets. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Vericel Corp's Long Term Investments and Total Assets is 0.89. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Total Assets in the same time period over historical financial statements of Vericel Corp Ord, assuming nothing else is changed. The correlation between historical values of Vericel Corp's Long Term Investments and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of Vericel Corp Ord are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Long Term Investments i.e., Vericel Corp's Long Term Investments and Total Assets go up and down completely randomly.

Correlation Coefficient

0.89

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Long Term Investments

Long Term Investments is an item on the asset side of Vericel Corp balance sheet that represents investments Vericel Corp Ord intends to hold for over a year. Vericel Corp Ord long term investments may include different instruments such as stocks, bonds, real estate and cash.

Total Assets

Total assets refers to the total amount of Vericel Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vericel Corp Ord books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most indicators from Vericel Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vericel Corp Ord current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

At this time, Vericel Corp's Selling General Administrative is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 621.77 this year, although the value of Issuance Of Capital Stock will most likely fall to about 5 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	113.9M	126.8M	142.0M	149.1M
Cost Of Revenue	50.2M	54.6M	61.9M	65.0M

Total Operating Expenses Cost Of Revenue

Vericel Corp fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock Total Equity	Short Term Investments	Common Stock	Inventory	Property Plant Equipment
Total Assets		0.94	0.46	0.94	0.99	0.97	0.48	-0.62	0.92	0.94	0.97	0.95	0.98	0.85	0.9	0.84	0.85	0.95	0.9	0.99	0.91	0.73	0.76	0.92	0.95	0.96
Short Long Term Debt Total	0.94		0.33	0.84	0.89	0.95	0.7	-0.36	0.84	0.89	0.94	0.85	0.9	0.75	0.98	0.87	0.8	0.97	0.87	0.9	0.91	0.58	0.69	0.77	0.86	0.9
Other Current Liab	0.46	0.33		0.57	0.48	0.4	0.02	-0.32	0.36	0.37	0.44	0.51	0.37	0.34	0.3	0.21	0.55	0.4	0.29	0.47	0.24	0.25	0.47	0.45	0.53	0.52
Total Current Liabilities	0.94	0.84	0.57		0.91	0.93	0.43	-0.62	0.94	0.9	0.93	0.85	0.92	0.75	0.83	0.86	0.94	0.92	0.91	0.91	0.87	0.76	0.64	0.87	0.88	0.89
Total Stockholder Equity	0.99	0.89	0.48	0.91		0.93	0.37	-0.69	0.89	0.91	0.94	0.98	0.98	0.88	0.84	0.79	0.8	0.9	0.85	0.99	0.89	0.76	0.81	0.96	0.95	0.95
Property Plant And Equipment Net	0.97	0.95	0.4	0.93	0.93		0.59	-0.51	0.91	0.95	1.0	0.85	0.94	0.74	0.95	0.92	0.88	0.98	0.94	0.92	0.92	0.66	0.61	0.84	0.88	0.94
Net Debt	0.48	0.7	0.02	0.43	0.37	0.59		0.19	0.4	0.38	0.57	0.31	0.44	0.26	0.73	0.57	0.5	0.66	0.48	0.39	0.56	-0.01	0.3	0.21	0.38	0.51
Retained Earnings	-0.62	-0.36	-0.32	-0.62	-0.69	-0.51	0.19		-0.59	-0.55	-0.52	-0.66	-0.7	-0.79	-0.31	-0.4	-0.39	-0.42	-0.44	-0.66	-0.51	-0.64	-0.51	-0.86	-0.61	-0.58
Accounts Payable	0.92	0.84	0.36	0.94	0.89	0.91	0.4	-0.59		0.91	0.91	0.82	0.92	0.72	0.82	0.91	0.91	0.89	0.94	0.89	0.89	0.81	0.6	0.84	0.83	0.81
Cash	0.94	0.89	0.37	0.9	0.91	0.95	0.38	-0.55	0.91		0.95	0.85	0.91	0.74	0.9	0.88	0.84	0.93	0.94	0.91	0.84	0.77	0.54	0.84	0.89	0.89
Non Current Assets Total	0.97	0.94	0.44	0.93	0.94	1.0	0.57	-0.52	0.91	0.95		0.87	0.94	0.75	0.95	0.89	0.88	0.98	0.92	0.93	0.9	0.65	0.63	0.85	0.91	0.96
Cash And Short Term Investments	0.95	0.85	0.51	0.85	0.98	0.85	0.31	-0.66	0.82	0.85	0.87		0.94	0.9	0.77	0.68	0.73	0.83	0.77	0.99	0.83	0.74	0.9	0.93	0.95	0.91
Net Receivables	0.98	0.9	0.37	0.92	0.98	0.94	0.44	-0.7	0.92	0.91	0.94	0.94		0.9	0.87	0.82	0.8	0.92	0.87	0.98	0.9	0.76	0.76	0.95	0.94	0.93
Common Stock Shares Outstanding	0.85	0.75	0.34	0.75	0.88	0.74	0.26	-0.79	0.72	0.74	0.75	0.9	0.9		0.67	0.57	0.53	0.73	0.62	0.9	0.74	0.65	0.8	0.94	0.86	0.82
Non Current Liabilities Total	0.9	0.98	0.3	0.83	0.84	0.95	0.73	-0.31	0.82	0.9	0.95	0.77	0.87	0.67		0.86	0.82	0.98	0.87	0.85	0.84	0.53	0.55	0.71	0.85	0.9
Other Current Assets	0.84	0.87	0.21	0.86	0.79	0.92	0.57	-0.4	0.91	0.88	0.89	0.68	0.82	0.57	0.86		0.86	0.89	0.96	0.78	0.93	0.69	0.44	0.7	0.67	0.74
Other Stockholder Equity	0.85	0.8	0.55	0.94	0.8	0.88	0.5	-0.39	0.91	0.84	0.88	0.73	0.8	0.53	0.82	0.86		0.89	0.9	0.8	0.79	0.68	0.53	0.7	0.79	0.79
Total Liab	0.95	0.97	0.4	0.92	0.9	0.98	0.66	-0.42	0.89	0.93	0.98	0.83	0.92	0.73	0.98	0.89	0.89		0.92	0.9	0.88	0.63	0.61	0.79	0.89	0.93
Property Plant And Equipment Gross	0.9	0.87	0.29	0.91	0.85	0.94	0.48	-0.44	0.94	0.94	0.92	0.77	0.87	0.62	0.87	0.96	0.9	0.92		0.85	0.9	0.82	0.51	0.76	0.79	0.81
Total Current Assets	0.99	0.9	0.47	0.91	0.99	0.92	0.39	-0.66	0.89	0.91	0.93	0.99	0.98	0.9	0.85	0.78	0.8	0.9	0.85		0.89	0.77	0.83	0.95	0.96	0.93
Short Term Debt	0.91	0.91	0.24	0.87	0.89	0.92	0.56	-0.51	0.89	0.84	0.9	0.83	0.9	0.74	0.84	0.93	0.79	0.88	0.9	0.89		0.71	0.69	0.82	0.75	0.8
Common Stock Total Equity	0.73	0.58	0.25	0.76	0.76	0.66	-0.01	-0.64	0.81	0.77	0.65	0.74	0.76	0.65	0.53	0.69	0.68	0.63	0.82	0.77	0.71		0.54	0.77	0.69	0.58
Short Term Investments	0.76	0.69	0.47	0.64	0.81	0.61	0.3	-0.51	0.6	0.54	0.63	0.9	0.76	0.8	0.55	0.44	0.53	0.61	0.51	0.83	0.69	0.54		0.78	0.77	0.72
Common Stock	0.92	0.77	0.45	0.87	0.96	0.84	0.21	-0.86	0.84	0.84	0.85	0.93	0.95	0.94	0.71	0.7	0.7	0.79	0.76	0.95	0.82	0.77	0.78		0.9	0.88
Inventory	0.95	0.86	0.53	0.88	0.95	0.88	0.38	-0.61	0.83	0.89	0.91	0.95	0.94	0.86	0.85	0.67	0.79	0.89	0.79	0.96	0.75	0.69	0.77	0.9		0.96
Property Plant Equipment	0.96	0.9	0.52	0.89	0.95	0.94	0.51	-0.58	0.81	0.89	0.96	0.91	0.93	0.82	0.9	0.74	0.79	0.93	0.81	0.93	0.8	0.58	0.72	0.88	0.96

Click cells to compare fundamentals

Vericel Corp Account Relationship Matchups

Vericel Corp fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	153.2M	205.6M	243.7M	273.0M	353.7M	371.3M
Other Current Liab	41K	11.3M	14.0M	16.2M	7.9M	8.3M
Total Current Liabilities	19.8M	22.5M	26.1M	37.5M	45.7M	48.0M
Total Stockholder Equity	111.1M	134.3M	170.5M	192.3M	226.0M	237.2M
Property Plant And Equipment Net	32.2M	57.7M	59.0M	57.4M	115.1M	120.9M
Net Debt	814K	19.6M	(18.2M)	(3.5M)	19.0M	19.9M
Retained Earnings	(378.7M)	(375.8M)	(383.3M)	(400.0M)	(403.2M)	(383.0M)
Accounts Payable	6.3M	6.8M	9.0M	16.9M	22.3M	23.5M
Cash	26.9M	33.6M	68.3M	51.1M	86.9M	91.2M
Non Current Assets Total	41.6M	82.0M	85.2M	86.1M	148.0M	155.4M
Cash And Short Term Investments	69.7M	75.8M	103.4M	119.5M	109.6M	115.0M
Net Receivables	32.2M	34.5M	37.4M	46.5M	58.4M	61.3M
Common Stock Shares Outstanding	44.2M	47.3M	46.5M	47.1M	47.6M	50.0M
Liabilities And Stockholders Equity	153.2M	205.6M	243.7M	273.0M	353.7M	371.3M
Non Current Liabilities Total	22.4M	48.9M	47.2M	43.3M	82.0M	86.1M
Other Current Assets	3.0M	3.9M	4.2M	4.8M	24.6M	25.9M
Other Stockholder Equity	21K	127.6M	177.9M	592.3M	681.1M	715.2M
Total Liab	42.1M	71.3M	73.2M	80.7M	127.7M	134.1M
Property Plant And Equipment Gross	32.2M	30K	59.0M	57.4M	137.3M	144.2M
Total Current Assets	111.7M	123.6M	158.5M	186.9M	205.6M	215.9M
Accumulated Other Comprehensive Income	21K	14K	(154K)	(978K)	(100K)	(105K)
Common Stock Total Equity	489.7M	6.6M	553.9M	593.2M	682.2M	716.3M
Short Term Investments	42.8M	42.2M	35.1M	68.5M	40.5M	42.5M
Common Stock	489.7M	510.1M	553.9M	593.2M	629.2M	660.7M
Inventory	6.8M	9.4M	13.4M	16.0M	13.1M	13.7M
Property Plant Equipment	32.2M	57.7M	59.0M	57.4M	66.0M	69.3M
Net Tangible Assets	111.1M	134.3M	170.5M	184.8M	212.5M	223.1M
Retained Earnings Total Equity	(378.7M)	(375.8M)	(383.3M)	(400.0M)	(360.0M)	(378.0M)
Non Currrent Assets Other	89K	211K	528K	1.3M	771K	732.5K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:

How To Invest In Vericel

Details

Is Vericel Stock a good investment?

Details

What is Vericel Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.045

Earnings Share

0.08

Revenue Per Share

4.685

Quarterly Revenue Growth

0.27

Return On Assets

(0)

The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vericel Long Term Investments vs Total Assets Analysis

Long Term Investments vs Total Assets

Long Term Investments vs Total Assets Correlation Analysis

Correlation Coefficient

Long Term Investments

Total Assets

Vericel Corp fundamental ratios Correlations

Vericel Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vericel Corp fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Cash And Short Term Investments
Net Receivables	+ 0.98	Total Assets

Common Stock	- 0.86	Retained Earnings
Common Stock Shares Outstanding	- 0.79	Retained Earnings
Net Receivables	- 0.7	Retained Earnings
Retained Earnings	- 0.69	Total Stockholder Equity
Total Current Assets	- 0.66	Retained Earnings
Cash And Short Term Investments	- 0.66	Retained Earnings